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NR0B1 geneAbstract Objective(s): X-linked adrenal hypoplasia congenital (X-linked AHC) is a rare disor-
der, characterized by infantile-onset acute primary adrenal insufficiency and hypogonadotropic
hypogonadism (HH) at an average age of three weeks and onset in roughly 40% is in childhood.
Its cause is an inactivating mutation in the (nuclear receptor subfamily 0, group B, member 1)
NR0B1 gene, DSS (dosage sensitive sex)-AHC vital region on the X-gene 1.
Subjects and methods: In the present study, the (dosage-sensitive, sex reversal, adrenal hypopla-
sia congenital, important region on the X-chromosome, gene 1) DAX-1 gene from four Iranian
patients with X-linked AHC was analyzed by means of polymerase chain reaction (PCR) and direct
sequencing.
Results: We identified a polymorphism (Rs6150) which encodes a cysteine (Cys) at position 38, a
de novo deletion, c.849-928del79 bp, c.849-856ins, (TGCTGCA) mutation and a missense muta-
tion, Leu262Gln, which encodes a leucine (Leu) for glutamine (Gln) at position 262.
Conclusion: Both mentioned mutations are located at crucial and functional region DAX1 pro-
tein. They are detected in the C-terminal region of DAX1 protein which is involved by the con-
served amino acid chain as well as transcriptional silencing domain. By considering other
investigation, mutations in this region probably lead to produce a misfolded protein. Consequently,
the misfolded protein would not work influentially in order to inhibit some gene expression. As a
result, our findings will expand the variety of DAX1 mutations. On the other hand, it is revealed
that these mutations play a key role in the pathogenesis of AHC, thus, recognizing these new muta-
tions will facilitate the patients prognosis producer as well as raising the clinical knowledge about
this rare disease.
 2016 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ngenital,
2 M. Davoodnejad et al.1. Introduction
Congenital adrenal hypoplasia (AHC) is a rare cause of con-
genital adrenal insufficiency and was first described by Sikl
[1]. It is estimated to affect 1 in 12,500 newborns [2]. X-
linked adrenal hypoplasia congenital (X-linked AHC) is an
inherited disorder of adrenal gland development, characterized
by absence or near absence of the permanent zone of the adre-
nal cortex [3]. AHC is mostly present in infancy or early child-
hood with primary adrenal failure with symptoms of salt-
wasting, hyperpigmentation, hyponatremia, hyperkalemia,
reduction of serum glucocorticoid and aldosterone and
increase in plasma (adrenocorticotropic hormone) ACTH
and affected boys typically have hypogonadotropic hypogo-
nadism (HH) at the time of puberty [3,4]. Overall, careful clin-
ical management of the affected children is important, because
rapid and life-threatening deterioration of adrenal function
frequently follows an asymptomatic period during infancy
[5]. Thus, early diagnosis ensures an early start of mineralocor-
ticoid and glucocorticoid treatment and prevents sudden
death.
The responsible gene for AHC is DAX1 which encodes a


















3-1 3 months Vomiting
Poor feeding
+ 
3-2 50 days Vomiting




Table 2 First laboratory findings.
Cases Naa Kb Ureac Creatinined ACTHe Cortis
1 117 6.5 26 0.7 1050 3.5
2 108 6.2 75 0.6 1200 1.5
3-1 119 4.6 30 0.7 1105 2
3-2 128 6.1 10 0.8 800 1.5
a Normal range for Neonate (132–147) mEq/L. Children (135–145) mE
b Normal range for Neonate (3.5–6.1) mEq/L. Children (3.5–5.1) mEq
c Normal range (5–18) mg/dl.
d Normal range (0.6–1.3) mg/dl.
e Normal range (7.2–63.3) pg/ml.
f Normal range in the morning (5–23) mcg/dl. In the afternoon (3–16)
g Normal range for prepubertal male <110 ng/dl.
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DAX1 (also called NROB1) gene in chromosome Xp21 are
responsible for the X-linked AHC [7]. The DAX1 gene is
composed of two exons separated by a single intron and
encodes a 470 amino acid [3,8]. Moreover, Ligand binding
domain is localized, similar carboxyl terminus of DAX1
protein to other nuclear receptors, but lacks the typical zinc
finger DNA-binding domain in the amino terminus. As an
alternative, the amino terminus consists of 3.5 alanine/
glycine-rich repeats of a 65–70 amino acid motif involved in
protein–protein interactions and may bind to hairpin loop
structure in DNA [2,9]. Previously, DAX1 expression has been
shown in the developing adrenal cortex, gonad, anterior
pituitary, and hypothalamus and also in the adult adrenal cor-
tex, anterior pituitary, the hypothalamic ventromedial nucleus,
Sertoli and Leydig cells in the testis, as well as theca and
granulose cells in the ovary [2,10]. DAX1 plays a principal role
as a transcriptional repressor in the gonadal and
adrenal development and in the regulation of gonadotropin
production [11].
The aim of this study was to characterize clinically and
genetically four Iranian patients with X-linked AHC plus
analyzing their NR0B1 gene.
2. Subjects and methods
2.1. Patients
This clinical trial was performed in Imam Reza Hospital
related to Mashhad Medical University, Mashhad (Iran) in
2013. The study was approved by local Ethics Committee
and also financially supported by the research vice chancellor
of the University. Informed consent was taken from all cases
parents and the study was approved by it. After obtaining
approval and written consent, 4 children who were diagnosed
with AHC and confirmed by a pediatric physician were
selected to investigate their mutation.
Clinical symptoms in patients and laboratory findings
respectively are presented in Tables 1 and 2. All of the cases
are under treatment with Hydrocortisone and Fludrocortisone
and also 100 mg of Testosterone, monthly. They did not show
any secondary sex characteristics when they were 14 year old.
Overall, by considering their clinical histories and test results,








in Iranian patients’ DAX-1 gene with X-linked adrenal hypoplasia congenital,
Table 3 Laboratory findings at 14.5 years cases.
LHa FSHb Tc CPKd Aldolasee ACTHf Nag Kh
1 0.12 0.13 <10 86 4.36 789 139 4.1
2 0.6 0.9 <10 73 5.2 70 142 4.3
3-1 0.45 1.8 <10 47 6.53 315 143 4.2
3-2 0.5 1.4 <10 143 9.2 >810 139 3.9
a Normal range for tanner stage I: (0.04–3.6), St II: (0.2–4.8), St III: (0.5–6.3), St IV and V: (0.56–7.8) mlu/m.
b Normal range for stage I: <1.3, St II: (1–7), St III: (2–9), St IV: (2–10), St V: (3–12) mlu/ml.
c Normal range for stage I: (2–23), St II: (5–70), St III: 15–210), St IV: (86–401), St V: (200–685) ng/dl.
d Normal range (40–225) U/L.
e Normal range(Up to 7.6) IU/L.
f Normal range (7.2–63.3) pg/ml.
g Normal range for adults (135–145) mEq/L.
h Normal range for adults (3.5–5.5) mEq/L.
Table 4 Sequence of primers.
Primer Sequence Product length (bp) Annealing temperature (C)
DAX1.For Ex1.F1 TGAGACAGGGAAAGGGGTAAT 423 53.9
DAX1.Rev Ex1.F1 CCGGGCTCATCGCCGCACGAA 423 72.4
DAX1.For Ex1.F2 TGGTGGATCAGTGTTGGGGC 241 60.0
DAX1.Rev Ex1.F2 CCGGGATCAGAGCCGCACGAA 241 67.9
DAX1.For Ex1.F3 AAGCAAACGTACGCGGCAC 279 58.3
DAX1.Rev Ex1.F3 CCTCTGCGCGAAGTAGGAGC 279 58.7
DAX1.For Ex1.F4 TAGCTCAAAGCAAACGCACGTG 426 59.9
DAX1.Rev Ex1.F4 GACGCCCAGCAGTTGCGCAC 426 65.6
DAX1.For Ex1.F5 GCCTCAGCGGGCCTGTTGAAG 450 64.7
DAX1.Rev Ex1.F5 CCCGATGCTTTTGTGAGCTGGGAA 450 66.7
DAX1.For Ex2.F6 GCTAGCAAAGGACTCTGTGGT 321 52.5
DAX1.Rev Ex2.F6 TGTGTGGCCCACATGACTTTA 321 55.9
Identification of mutations in DAX-1 gene 3consequently, they were administered to our genetic investiga-
tion (see Table 3).
2.2. Polymerase chain reaction (PCR) and direct sequencing of
the DAX-1 gene
DNA was extracted from patients’ blood leukocytes using the
standard method of salting out. Both exons of DAX1 were
PCR amplified using six primer pairs, presented in the Table 4.
These primers are designed based on published article
‘‘Mutational Analysis of DAX1 in Patients with
Hypogonadotropic Hypogonadism or Pubertal Delay”. They
are synthesized by Takapouzist biological company, Tehran,
Iran.
PCR was optimized by varying annealing temperature and
primer ratios. Briefly, the optimized condition was performed
in a mixture of 2 lL DNA 1 lL forward primer and reverse
primer, 8.5 lL distilled water with 12.5 lL master mix of red
2 Amplicon.
The PCR profile was as follows: initial denaturation at
95 C for 5 min followed by 35 cycles of denaturation at
95 C for1 min, the optimized primer annealing at 58 C–
65 C for the 30 s–1 min and extension at 72 C for 5 min.
PCR reactions were performed using TECHNE Applied
Biosystems Thermocycler and PCR productions were sent to
Harvard University for direct sequencing.Please cite this article in press as: Davoodnejad M et al., Identification of mutations
Egypt J Med Hum Genet (2016), http://dx.doi.org/10.1016/j.ejmhg.2016.05.0023. Result
3.1. PCR-direct sequencing of the DAX-1 gene
In 4 Iranian patients, one missense mutation (L262Q) in two
brothers and a novel mutation c.849-928del79 bp, c.849-
856ins (TGCTGCA) in one case and an Rs6150 polymorphism
were identified. In case 1, Rs6150 polymorphism, was due to a
transition of C to T at nucleotide 114, that both of them
encoding cysteine (Cys) at position 38 was identified (Figs. 1
and 2). In case 2, novel deletion mutation was identified. This
mutation had a deletion of 79 bases at positions 283 to 310
with the insertion of 7 nucleotides (TGCTGCA) (Figs. 3–7).
Only the patient’s brother has not shown any symptom of
the disease. His mother was analyzed for mutation of
NR0B1 gene, but no mutations were identified. However, 3-1
and 3-2 patients have same parents, it is revealed that both
of them are carrying missense mutation L262Q (c.785 T>A).
This mutation was due to a transversion of T to A at nucleo-
tide 785, which encodes a leucine (Leu) for glutamine (Gln) at
position 262 (Figs. 8 and 9).
4. Discussion
The association between DAX-1 and X-linked AHC is well-
established, and many mutations in DAX-1 have been depictedin Iranian patients’ DAX-1 gene with X-linked adrenal hypoplasia congenital,
Figure 1 Electrophoresis of the PCR-amplified productions of F1 (first fragment of exon1) in agarose gel (2%).
Figure 2 Partial nucleotide sequence of the DAX-1 gene, exon 1,
fragment 1 of case 1, for Rs6150 polymorphism. Figure 3 Electrophoresis of the PCR-amplified productions of
F5 (fifth fragment of exon1) in agarose gel (2%).
4 M. Davoodnejad et al.in patients with this condition. In the present study, we identi-
fied two mutations, including one missense mutation, one de
novo deletion and insertion mutation of the DAX-1 gene in
patients with X-linked AHC and also we identified one poly-
morphism. The current identified missense mutation of c.785
T > A is encoding a leucine (Leu) for glutamine (Gln) at posi-
tion 262 was detected in two brothers. These patients had
repeated vomiting strikingly in addition case 3-2 had more sev-
ere symptoms than case 3-1. Interestingly, family history
demonstrates that 2 infants had died for repeated vomiting.
Similarly as Muscatelli et al. (1994) reported that adrenal
insufficiency typically presents acutely in male infants with
vomiting, feeding difficulty, dehydration, and shock caused
by a salt-wasting episode [6]. In addition, Bae et al. (1996)
declared that missense mutations may be important for identi-
fying critical regions or amino acids necessary for DAX-1
function [12]. Actually, DAX1 as an orphan receptor
belonging to the superfamily has the N-terminal region of
DAX1 is considered to serve as a DNA-binding domain and
the C-terminal region contains a putative ligand-binding
domain [2]. Comparably, most missense mutations of the
DAX-1 gene are located in the C-terminal presumptive
ligand-binding domain [12]. The Leu262Gln mutation isPlease cite this article in press as: Davoodnejad M et al., Identification of mutations
Egypt J Med Hum Genet (2016), http://dx.doi.org/10.1016/j.ejmhg.2016.05.002located in the C-terminal presumptive ligand binding
(Fig. 10). Generally, all DAX-1 missense mutations reported
to date affect amino acids that are conserved completely in
all species in which a DAX-1 homolog has been cloned, even
including the chicken and alligator [13,14]. This finding shows
the importance of a C-terminal region that conserved amino
acids may play a functional role for Dax1 protein. DAX-1 mis-
sense mutations affect amino acids that form the hydrophobic
core of the DAX-1 (ligand bonding domain) LBD. These
amino acids may affect subdomain structure rather than ligand
binding and may be involved in ligand-independent interac-
tions such as dimerization [15]. It is also possible that the
amino-terminus of DAX-1 is not important for its function.
More likely, the repeated nature of the domains within the
amino-terminus may serve redundant functions, such that sin-
gle amino acid substitutions are not sufficient to cause com-
plete loss of function. The transcriptional silencing domain
of DAX1 has been mapped to a bipartite region in the C-
terminal LBD-like (LBD-L) domain which includes two
groups of residues, one at each end of the LBD-L [16]. Inter-
estingly, all documented AHC missense mutations also map
to this region [15], and it has been shown that AHC mutations
abolish transcriptional silencing activity, suggesting that a lackin Iranian patients’ DAX-1 gene with X-linked adrenal hypoplasia congenital,
Figure 4 Forward partial nucleotide sequences of the DAX-1 gene, exon 1, fragment 5 of a normal case.
Figure 5 Forward partial nucleotide sequences of the DAX-1 gene, exon 1, fragment 5 of case 2 for c.849-928del79 bp, c.849-856ins
(TGCTGCA) mutation.
Figure 6 Reverse partial nucleotide sequences of the DAX-1 gene, exon 1, fragment 5 of a normal case.
Identification of mutations in DAX-1 gene 5of silencing could be involved in the pathogenesis of AHC. In
spite of all that more studies are needed to identifying the
effect of L262Q on DAX1 protein and pathogenesis of AHC.
A de novo deletion mutation is a rare event and a de novo
deletion c. 849-928del79 bp, c.849-856ins (TGCTGCA) of thePlease cite this article in press as: Davoodnejad M et al., Identification of mutations
Egypt J Med Hum Genet (2016), http://dx.doi.org/10.1016/j.ejmhg.2016.05.002DAX-1 gene has not previously been reported. Identification
of a case of a de novo deletion mutation of the DAX-1 gene
reinforces the importance of molecular analysis of the patient’s
mother for genetic counseling. The mother of case 2 told us that
she didn’t have another affected or carrier child. Although wein Iranian patients’ DAX-1 gene with X-linked adrenal hypoplasia congenital,
Figure 7 Reverse partial nucleotide sequences of the DAX-1 gene, exon 1, fragment 5 of case 2 for c.849-928del79 bp, c.849-856ins
(TGCTGCA) mutation.
Figure 8 Electrophoresis of the PCR-amplified productions of
F4 (fourth fragment of exon 1) in agarose gel (2%).
Figure 9 Partial nucleotide sequence of the DAX-1 gene, exon 1,
fragment 4 of case 3-1 and 3-2 for c.785 T > Amutation.
Figure 10 Naturally occurring DAX-1 missense mutations
cluster within the carboxyl-terminus of DAX-1 in a region
homologous to the LBD of other nuclear receptors. The repeat
motif structure of the amino-terminus of DAX-1 is shown by
arrows. The carboxyl-terminal putative AF2 domain is shaded.
The carboxyl-terminal putative AF2 domain is shaded. Previously
reported potential transcriptional silencing domains are shown by
black bars [17].
6 M. Davoodnejad et al.cannot totally exclude the possibility that gonadal mosaicism
does exist for DAX-1 mutations, patients with X-linked AHC
due to gonadal mosaicism have not been reported. Indeed,
the evidence that a mother and elder brother of case 2 havePlease cite this article in press as: Davoodnejad M et al., Identification of mutations
Egypt J Med Hum Genet (2016), http://dx.doi.org/10.1016/j.ejmhg.2016.05.002no deletion of the DAX-1 gene may exclude the possibility of
gonadal mosaicism in this family. This deletion occurred in
C-terminal of DAX1 protein. The majority of functional data
reported suggesting that DAX-1 represses the transcription of
several genes expressed in the adrenal and reproductive axes,
either directly or through an interaction with the related orphan
nuclear receptor steroidogenic factor-1 (SF-1) [16]. Some stud-
ies have suggested that this repressor function may involve
specific transcriptional silencing domains within the carboxyl-
terminus of DAX-1 [17] whereas others have proposed that
DAX-1 can bind directly to hairpin loop structures in the pro-
moters of certain target genes [9]. Further, direct interactions
between DAX-1 and repressors such as nuclear receptor and
corepressor (NCoR) [18] and Alien [19] have been described.
However, the relative importance of these mechanisms in the
regulation of different target genes remains unclear. This dele-
tion may cause misfolding DAX1 protein and will not be able
to interact with corepressors so, will not have correct interac-
tion with ligands such as SF1 (Fig. 11). Indeed, loss of as little
as 9 amino acids at the carboxyl-terminus of DAX-1 is suffi-
cient to impair DAX-1 function and to produce a clinically sev-
ere phenotype [20].
In the Li et al. survey some missense and deletion mutations
in the C-terminal region of DAX1 protein were identified.in Iranian patients’ DAX-1 gene with X-linked adrenal hypoplasia congenital,
Figure 11 Mechanisms of DAX1-mediated repression of SF1,
ER, and LRH-1. DAX1 binds the AF-2 domain of the nuclear
receptors via its LXXLL motifs and recruits corepressor proteins
to target gene promoters [2].
Identification of mutations in DAX-1 gene 7Through this study, the transcriptional activities of the identi-
fied mutations were assessed in vitro and showed loss of
repression of SF-1-mediated (steroidogenic acute regulatory
protein) StAR and (luteinizing hormone beta-subunit) LHb
expression. Furthermore, they found that DAX1 mutation
resulted in a reduction of (Gonadotrophin-releasing hormone)
GnRH expression, which is associated with HHG [21]. In spite
of all this the study suggested more investigation into identify-
ing the effect of this novel mutation on DAX1 protein struc-
ture, function and pathogenesis of AHC is needed.
We also identified one synonymous polymorphism c.114C.
T (rs6150) in NR0B1 gene in a patient. This polymorphism is
located within the first exon, and neither changes the predicted
amino acid. Even though this DNA change has not been exam-
ined experimentally for their effect on mRNA or protein
expression, Phelan and McCabe, 2001 stated that this nucleo-
tide change does not co-segregate with the disease phenotype
which confirms that this is a true polymorphism, through
repeated observations by different groups [22]. Conversely, it
is interesting that while case 1 had more severe and obvious
symptoms for AHC disease, no mutations were found for it
and just the c.114C.T (rs6150) polymorphism is identified. This
study suggests more investigation is needed for correlation
between c.114C.T (rs6150) and AHC disease.
In conclusion, two different mutations are characterized in
the C-terminal domain of DAX-1 including a missense muta-
tion and a de novo deletion of the DAX-1 gene. These muta-
tions lead to disruption in the ligand binding domain. Thus,
the normal biological activity of the DAX-1 protein, such as
adrenal embryogenesis and/or hypothalamic-pituitary activity
may influence these mutations. On the other hand, the identi-
fication of a novel de novo deletion of the DAX-1 gene rein-
forces the importance of family genetic counseling for a
patient with X-linked AHC and HH. As a result, our findings
will expand the number of DAX1 mutations reported in the lit-
erature, however, it will highlight the role of these mutations
the pathogenesis of AHC. Finally, all data will facilitate the
patients’ prognosis procedure as well as increase clinical
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